Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Control and function of repressive chromatin domains

Award Number: R35GM152134
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/12/2024
PERIOD OF PERFORMANCE END DATE: 05/31/2029

Group Awards By:

View Award Description

Control and function of repressive chromatin domains - Project Summary/Abstract The long-term goals of this project are to understand the composition, assembly, and function of specialized chromatin domains. Polycomb Group (PcG) proteins interact to form enzyme complexes that modify chromatin and assemble repressed chromatin states in animals, plants, and some fungi. Polycomb Repressive Complex 2 (PRC2) is a highly conserved histone methyltransferase complex that is essential for multicellular development and plays key roles in maintenance of stem cell identify, X-chromosome inactivation, and gene regulation. Mutations that alter PRC2 function are responsible for human Weaver syndrome and multiple cancers. Despite the importance of PcG proteins in human health and nearly 80 years of investigation, important mechanistic details regarding the establishment and epigenetic inheritance of PcG repressed chromatin remain unknown. Our studies with the model fungus Neurospora crassa have begun to address these critical gaps in knowledge. N. crassa is a powerful experimental system that shares key features of the PcG system with higher eukaryotes. Importantly, components of PRC2 are structurally and functionally conserved, in contrast to major yeast models Saccharomyces cerevisiae and Schizosaccharomyces pombe. Our recent efforts have uncovered new genes required for PcG repression and have begun to generate mechanistic insights into their functions. We will apply hypothesis-driven genetic, molecular, proteomic, and genomic approaches to define functions of newly identified genes, and we will perform discovery-driven genetic screens to identify new regulators and components of Polycomb repressed chromatin domains. Major questions will be addressed during the grant period include. 1) What are the mechanisms that control de novo establishment, spreading, and epigenetic inheritance of H3K27me3? 2) How does ISWI, a nucleosome sliding ATP-dependent chromatin remodeling enzyme control to assembly and maintenance of PcG repressed domains? 3) How are H3K27me3 levels re- established following DNA replication? 4) What other factors control and comprise PcG-repressed chromatin domains? Successful completion of the proposed aims will uncover general principles and mechanisms governing assembly and function of PcG-repressed chromatin domains. Findings from these studies will serve as a framework for future studies in higher eukaryotes, including humans. In addition, because PcG proteins are linked to cancer and other genetic diseases, understanding the regulation and function of these key chromatin regulators will ultimately improve diagnosis and treatment of human disease.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $365,002 )
2025	2025	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Biomedical Research and Research Training	001	2	5/30/2025	NON-COMPETING CONTINUATION	$365,002
2025	2024	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Biomedical Research and Research Training	000	1	11/6/2024	NEW	$0
														Subtotal = $365,002

Issue Date FY: 2024 ( Subtotal = $393,512 )
2024	2024	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Biomedical Research and Research Training	000	1	7/12/2024	NEW	$393,512
														Subtotal = $393,512

Grand Total All Awards = $758,514

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Control and function of repressive chromatin domains

Award Number: R35GM152134

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/12/2024

PERIOD OF PERFORMANCE END DATE: 05/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer